Jonas Blomberg

Jonas Blomberg, MD, PhD, (1944-2019) was an Emeritus Professor at the Department of Medical Sciences, Clinical Microbiology, Uppsala University, Sweden. He was on the Advisory Board of the Gottfries Clinic, one of the couple of clinics in Sweden offering adequate biomedical treatment for Fibromyalgia and ME/CFS.

Blomberg passed away suddenly in February 2019.

Education

• 1974 - MD, Göteborg University
• 1977 - PhD in Medical Biochemistry, Göteborg University
• 1979-1981 - Postdoctoral work on Retroviruses, National Cancer Institute, US

Fields of Research

• Retroviruses: HIV, HTLV, XMRV and HERVs.
• Bioinformatics: Improving diagnostic methods for clinical microbiology, enhancing phylogenetic studies.
• Method development: Nucleic acid and Antibody based methods for detection of infection.
• Clinical Virology: Quality control, management of routine, search for infectious triggers of Myalgic encephalomyelitis (chronic fatigue syndrome).

2017 Ramsay Award

A team comprised of Dr. Blomberg and Dr. Jonas Bergquist of Uppsala University and Dr. Carl-Gerhard Gottfries and Dr. Olof Zachrisson of the Gottfries Clinic were awarded a 2017 Ramsay Award grant from the Solve ME/CFS Initiative for research into biomarkers for initiation (infection) and metabolic derangement in ME/CFS.

Committees and working groups

ME/CFS Collaborative Research Center at Stanford University

Member of the Working Group which offers their expertise and resources to the ME/CFS Collaborative Research Center at Stanford University.

EUROMENE

Member of the Biomarkers Working Group of ME/CFS across Europe on behalf of the EUROMENE, a European Union COST Action CA15111 not-for-profit research organization committed to tackling the cause and treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Research on ME/CFS

• 2011, Murine gammaretrovirus group G3 was not found in Swedish patients with myalgic encephalomyelitis/chronic fatigue syndrome and fibromyalgia - (Full Text)
• 2011, Phylogeny-directed search for murine leukemia virus-like retroviruses in vertebrate genomes and in patients suffering from myalgic encephalomyelitis/chronic fatigue syndrome and prostate cancer - (Full Text)
• 2012, No evidence for xenotropic murine leukemia-related virus infection in Sweden using internally controlled multiepitope suspension array serology - (Full Text)
• 2013, Epitopes of Microbial and Human Heat Shock Protein 60 and Their Recognition in Myalgic Encephalomyelitis - (Full Text)
• 2018, Infection Elicited Autoimmunity and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An Explanatory Model - (Full Text)
• 2019, Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients - (Abstract)

Talks and interviews

• 2013, Jonas Blomberg om sökande efter mikrobiella biomarkörer vid ME/CFS
• 2014, 9th Invest in ME International ME Conference 2014 (no speech title given, but he discussed infection-induced autoimmunity in ME)DVD on conference

Online presence

• Wiki page (in Swedish)
• Uppsala University faculty page
• Twitter

See also

• Sweden

Learn more

• A loss to the ME community: Jonas Blomberg by Jaime Seltzer

antibodies Antibody/immunoglobulin refers to any of a large number of specific proteins produced by B cells that act against an antigen in an immune response.

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

See myalgic encephalomyelitis.

See chronic fatigue syndrome.

genome an organism's complete set of DNA, including all of its genes

antibodies Antibody/immunoglobulin refers to any of a large number of specific proteins produced by B cells that act against an antigen in an immune response.

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.